Teva digital asthma inhaler wins FDA nod

Teva
Teva

The ArmonAir Digihaler is for the treatment of asthma in patients 12 years and older.

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) announced today that the US Food and Drug Administration (FDA) has approved ArmonAir Digihaler (fluticasone propionate). ArmonAir Digihaler dispenses inhalation powder, an inhaled corticosteroid (ICS), delivered via Teva’s Digihaler device, which contains built-in sensors and connects to a companion mobile application that provides information on inhaler use to people with asthma.

ArmonAir Digihaler is for the treatment of asthma in patients 12 years and older. ArmonAir® Digihaler™ is not indicated for the relief of acute bronchospasm.

ArmonAir Digihaler joins the approved Digihaler portfolio of products, including ProAir Digihaler (albuterol sulfate 117 mcg) Inhalation Powder, for use in patients 4 years of age and older to treat or prevent bronchospasm in those who have reversible obstructive airway disease and to prevent exercise-induced bronchospasm, and AirDuo Digihaler (fluticasone propionate and salmeterol) Inhalation Powder, which for the treatment of asthma in patients 12 years of age and older.

The Digihaler device detects when the inhaler is used and measures inspiratory flow rates. These data are then sent to a companion mobile app using Bluetooth® Wireless Technology so that patients can review their data over time, and if desired, share it with their healthcare providers to have more informed discussions about their condition and treatment. Patients also can schedule reminders on their smartphone to take either their ArmonAir Digihaler or AirDuo Digihaler as prescribed.

Teva EVP global marketing and portfolio Sven Dethlefs said, "The approval of a third product in the Digihaler portfolio is an incredibly exciting milestone for us. Our portfolio now includes a rescue treatment, a maintenance combination therapy, and now a maintenance monotherapy. All three of these digital inhalers with built-in sensors pair with companion mobile apps, allowing patients to track their inhaler use across multiple digital devices and have a better understanding of their condition. Patients may also choose to share this data with their healthcare providers."

Published by Globes, Israel business news - en.globes.co.il - on February 24, 2020

© Copyright of Globes Publisher Itonut (1983) Ltd. 2020

Intel's 2025 vision credit: Intel Will Intel's sell-off include Israeli assets?

After the sale of Altera, "Globes" considers whether the troubled chipmaker will sell Mobileye or its Kiryat Gat fab.

CloudShare management team credit: PR Bow River Capital buys Israeli co CloudShare

The Denver-based alternative asset manager is paying an estimated $60-80 million for the SaaS provider of AI guided solutions for complex technical training requirements.

Housing prices continue to rise   credit: Tali Bogdanovsky Israel's housing price rise riddle

Despite a huge inventory of unsold new homes in central Israel and weak sales, apartment prices are still rising. "Globes" analyzes the data.

Inflation  credit: Tali Bogdanovsky March CPI higher than expected, housing prices rise

The March reading brings annual inflation in Israel down to 3.3% from 3.4% at the end of February.

Ben Gurion airport credit: Tali Bogdanovsky Abundance of affordable last minute Passover flight deals

The return of foreign airlines to Israel has brought down fares dramatically even for last minute vacations.

Karish rig  credit: Eyal Izhar Kesem Energy signs gas deals worth $2.8b

The power plant, scheduled to begin operating in 2029, will buy gas worth $2 billion from Energean and a further $700-800 million from the Tamar partners.

Kosher for Passover Coca Cola bottles credit: social media Why are yellow cap Coca Cola bottles different from all others?

Nostalgic Coca Cola aficionados claim that the kosher for Passover version, made from sugar cane instead of high fructose corn syrup, is the genuine taste of the soft drink.

Avigdor Willenz credit: Intel Exclusive: Avigdor Willenz's Element Labs raises $50m

The Israeli startup is developing AI processors for inference, the stage in which AI models are activated after they have already been trained.

Ilya Sutskever credit: Cadya Levy SSI hiring dozens in Israel

AI company Safe Superintelligence is hiring many dozens of people in Tel Aviv, "Globes" has learned.

Johny Srouji credit: Amos Ben Gershom GPO Apple SVP leads senior delegation of execs to Israel

Jony Srouji: I am always filled with renewed energy and optimism about our shared achievements when I visit our R&D centers here.

Israeli apartments Credit: Shutterstock Apartments sold and rented

A selection of recent real estate deals in Israel in Tel Aviv, Ramat Gan, Petah Tikva, Givat Shmuel, Tiberias and Dimona.

Infinity Tower Tel Aviv credit: Courtesy Hagag Group French investors buy 2 Tel Aviv apartments for NIS 27.5m

The two apartments are in Hagag Group's Infinity Tower in the Summeil district.

El Al plane credit: Shutterstock El Al receives state approval to distribute dividend

The Israeli airline has now announced that it will be able to distribute up to 30% of net profit in 2025 and up to 40% in 2026-2028.

groundcover founders credit: Yossi Yarom Israeli observability co groundcover raises $35m

groundcover has developed a “Bring Your Own Cloud” (BYOC) observability solution, redefining the architecture of a modern observability platform.

Tel Aviv Stock Exchange credit: Shutterstock MagioreStock Foreign investment in TASE hits five-year high

Foreign investors have been flocking to the Tel Aviv Stock Exchange in recent weeks, the TASE research department tells "Globes."

Elbit Systems tank turret systems credit: Elbit Systems Elbit Systems wins $100m tank turret systems deal

The Israel defense electronics company will supply its advanced UT30 MK2 unmanned turret systems to General Dynamics European Land Systems (GDELS) to be supplied to a NATO European country.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018